Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
| Website | http://www.allucent.com |
| Revenue | $361.6 million |
| Employees | 1,361 (766 on RocketReach) |
| Address | 2000 Centregreen Way Suite 300, Cary, North Carolina 27513, US |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Biotechnology, Biotech, Pharmaceutical, Drug Development, Clinical Trials, Therapeutics, Life Sciences, Healthcare, Medical Research, Biopharmaceutical, Drug Discovery, Regulatory Affairs, Small Molecule Drugs, Biologics, Pharmaceutical Manufacturing, Contract Research Organization, Clinical Research, Preclinical Research, Drug Delivery, Medical Technology |
| Competitors | ICON plc, IQVIA, Syneos Health, Parexel, Charles River Laboratories, Medpace, WuXi AppTec, Covance, Celerion +34 more (view full list) |
Looking for a particular Allucent employee's phone or email?
The Allucent annual revenue was $361.6 million in 2026.
Paula Stafford is the CEO of Allucent.
766 people are employed at Allucent.
Allucent is based in Cary, North Carolina.